| P2093 | author name string | Rafael Duran | |
| | Alban Denys | |
| | Cheryl Lai-Lai Chiang | |
| | Lana Kandalaft | |
| | Chakradhar Yakkala | |
| P2860 | cites work | Evolution of Metastases in Space and Time under Immune Selection | Q57481441 |
| | Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma | Q57949352 |
| | Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine | Q58620026 |
| | Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation | Q69487163 |
| | Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues | Q79369692 |
| | Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation | Q79451548 |
| | Serum cytokine levels in response to hepatic cryoablation | Q79548485 |
| | Cancer cryotherapy: evolution and biology | Q80297318 |
| | Professional antigen-presentation function by human gammadelta T Cells | Q81810232 |
| | Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative | Q88085789 |
| | EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma | Q88301343 |
| | Tumour decides immune cell ins and outs | Q89472959 |
| | Engineering T cell response to cancer antigens by choice of focal therapeutic conditions | Q91192839 |
| | Regression of prostatic cancer following sequential cryotherapy to the prostate | Q93729659 |
| | The urgent need to recover MHC class I in cancers for effective immunotherapy | Q26770165 |
| | The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer | Q26774678 |
| | Biophysiologic considerations in cryoablation: a practical mechanistic molecular review | Q26998566 |
| | γδ T cells for cancer immunotherapy: A systematic review of clinical trials | Q27021705 |
| | Immune escape mechanisms as a guide for cancer immunotherapy | Q27024502 |
| | The B7 family revisited | Q28240070 |
| | The history of cryosurgery | Q28363523 |
| | The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 |
| | Mechanisms of cryoablation: clinical consequences on malignant tumors. | Q30419671 |
| | Experimental cryosurgery investigations in vivo | Q30478360 |
| | Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model | Q33521401 |
| | Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy | Q33875615 |
| | Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 |
| | Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population | Q33928216 |
| | Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. | Q34205626 |
| | Remission of Metastatic Lesions Following Cryosurgery in Prostatic Cancer: Immunologic Considerations | Q34225753 |
| | Freezing of living cells: mechanisms and implications | Q34258159 |
| | Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer | Q34353635 |
| | Thermal ablation of tumours: biological mechanisms and advances in therapy. | Q34406134 |
| | Clinical use of dendritic cells for cancer therapy. | Q34421850 |
| | Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens | Q34788858 |
| | The cryobiology of cryosurgical injury | Q34807216 |
| | Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours | Q35208161 |
| | Progress toward optimization of cryosurgery | Q35731909 |
| | Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy | Q35920288 |
| | Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells | Q36370502 |
| | KINETICS OF WATER LOSS FROM CELLS AT SUBZERO TEMPERATURES AND THE LIKELIHOOD OF INTRACELLULAR FREEZING. | Q36374499 |
| | Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. | Q36611772 |
| | TLR agonists: our best frenemy in cancer immunotherapy | Q36850457 |
| | The prognostic landscape of genes and infiltrating immune cells across human cancers | Q36857285 |
| | Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma | Q36965049 |
| | Inhibitory B7-family molecules in the tumour microenvironment | Q37171804 |
| | Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses | Q37325106 |
| | A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling | Q37509479 |
| | Cryoimmunotherapy in urologic oncology | Q37598432 |
| | Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies | Q37729133 |
| | Cryoablation: mechanism of action and devices. | Q37775333 |
| | Toll-like receptor signaling pathways | Q38259564 |
| | CAR T Cell Therapy for Solid Tumors | Q38408512 |
| | Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives. | Q38571694 |
| | γδ T cells in cancer | Q38602555 |
| | Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape | Q38671364 |
| | Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid | Q38945626 |
| | Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy? | Q38984527 |
| | Dendritic Cells and Cancer Immunity. | Q38994017 |
| | Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo | Q39128768 |
| | Utility of PET/CT After Cryoablation for Early Identification of Local Tumor Progression in Osseous Metastatic Disease | Q39195755 |
| | Engineering Natural Killer Cells for Cancer Immunotherapy | Q39408704 |
| | Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells | Q39692550 |
| | Converting Cold into Hot Tumors by Combining Immunotherapies | Q40050679 |
| | A history of cryosurgery: its development and future. | Q40248553 |
| | Immunologic response to cryoablation of breast cancer | Q40446167 |
| | Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer | Q40696642 |
| | Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature | Q41619501 |
| | Liquid nitrogen in the treatment of skin diseases | Q42407990 |
| | Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application | Q42456030 |
| | A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer | Q42940016 |
| | Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma | Q44239994 |
| | Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma | Q44517849 |
| | Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. | Q45926166 |
| | Releasing the Brakes on Cancer Immunotherapy. | Q45976317 |
| | Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer | Q46056802 |
| | Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer | Q46199274 |
| | 0 °C is better?- Thawing temperature optimization study for cancer cryoablation in a mouse model with green fluorescent protein-labeled Lewis lung cancer | Q46405398 |
| | Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes | Q47093792 |
| | Current Advances in γδ T Cell-Based Tumor Immunotherapy | Q47100174 |
| | Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer | Q47105585 |
| | Intratumoral immunotherapy: using the tumor as the remedy | Q47281370 |
| | Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol | Q47295977 |
| | Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer | Q47571299 |
| | Oncogenes: Driving immune evasion | Q49716370 |
| | Characterization of the cryoablation-induced immune response in kidney cancer patients. | Q50502697 |
| | Thermal maps around two adjacent cryoprobes creating overlapping ablations in porcine liver, lung, and kidney. | Q51059479 |
| | Cooling cannula for use in the treatment of cerebral neoplasms. | Q51316965 |
| | Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. | Q51976721 |
| | Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. | Q51990684 |
| | Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. | Q52538833 |
| | Cancer immunotherapy using checkpoint blockade. | Q52641912 |
| | Next generation of immune checkpoint therapy in cancer: new developments and challenges. | Q52653710 |
| | Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer. | Q52770412 |
| | Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q52847414 |
| | Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study. | Q53051150 |
| | Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor. | Q53599386 |
| | γδ T Cells: Unexpected Regulators of Cancer Development and Progression. | Q54326921 |
| | Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. | Q55223108 |
| | The promise and challenges of immune agonist antibody development in cancer | Q56891562 |
| | Mechanisms of tissue injury in cryosurgery | Q57108848 |
| | DSC measurement of cell suspensions during successive freezing runs: implications for the mechanisms of intracellular ice formation | Q57111612 |
| | Immunological response of regional lymph nodes after tumor cryosurgery: experimental study in rats | Q57116241 |
| | Late appearance of resistance to tumor rechallenge following cryosurgery. A study in an experimental mammary tumor of the rat | Q57119331 |
| | Sensitivity of pigmented mucosa and skin to freezing injury | Q57120812 |
| | Cryosurgery of pulmonary metastases | Q57120949 |
| | Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate | Q57124741 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | immune system | Q1059 |
| | neoplasm | Q1216998 |
| | immunotherapy | Q1427096 |
| | cryosurgery | Q2705075 |
| P304 | page(s) | 2283 | |
| P577 | publication date | 2019-09-24 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors | |
| P478 | volume | 10 | |